We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.5B
AUM Growth
-$124M
Cap. Flow
-$427M
Cap. Flow %
-2.44%
Top 10 Hldgs %
21.6%
Holding
1,393
New
110
Increased
432
Reduced
589
Closed
137

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$68.9M
2
AMAT icon
Applied Materials
AMAT
+$65.9M
3
NFLX icon
Netflix
NFLX
+$53.9M
4
FISV
Fiserv Inc
FISV
+$51.8M
5
ROST icon
Ross Stores
ROST
+$50.5M

Top Sells

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$72.2M
2
CDW icon
CDW
CDW
+$64.9M
3
PH icon
Parker-Hannifin
PH
+$58.7M
4
CTRA
Coterra Energy
CTRA
+$51.4M
5
GPC icon
Genuine Parts
GPC
+$46.7M

Sector Composition

Rank Sector Weight
1 Technology 23.02%
2 Healthcare 12.68%
3 Consumer Discretionary 9.82%
4 Financials 9.37%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
51
iShares Russell 2000 ETF
IWM
$80.3B
$82.2M 0.47%
465,297
-29,847
-6% -$5.6M
NFLX icon
52
Netflix
NFLX
$296B
$80.8M 0.46%
2,140,380
+1,272,620
+147% +$53.9M
UNP icon
53
Union Pacific
UNP
$179B
$78.8M 0.45%
386,887
+13,462
+4% +$2.93M
HON icon
54
Honeywell
HON
$77.6B
$78.3M 0.45%
449,940
-6,605
-1% -$1.21M
VEA icon
55
Vanguard FTSE Developed Markets ETF
VEA
$226B
$78M 0.45%
1,784,710
+4,953
+0.3% +$227K
PH icon
56
Parker-Hannifin
PH
$124B
$76M 0.43%
195,133
-145,954
-43% -$58.7M
BMY icon
57
Bristol-Myers Squibb
BMY
$128B
$72.2M 0.41%
1,244,006
-362,524
-23% -$22.2M
COST icon
58
Costco
COST
$420B
$71.9M 0.41%
127,279
-3
-0% -$1.66K
PGR icon
59
Progressive
PGR
$126B
$71.7M 0.41%
514,831
-267,601
-34% -$35.2M
REGN icon
60
Regeneron Pharmaceuticals
REGN
$70.7B
$69.8M 0.4%
84,758
+1,257
+2% +$988K
EFA icon
61
iShares MSCI EAFE ETF
EFA
$76.8B
$68.4M 0.39%
992,546
+42,862
+5% +$3.07M
ITW icon
62
Illinois Tool Works
ITW
$82.2B
$68.1M 0.39%
295,580
-7,701
-3% -$1.88M
VRTX icon
63
Vertex Pharmaceuticals
VRTX
$122B
$67.6M 0.39%
194,393
-4,348
-2% -$1.52M
AME icon
64
Ametek
AME
$55.1B
$67M 0.38%
453,335
-17,896
-4% -$2.8M
IVV icon
65
iShares Core S&P 500 ETF
IVV
$869B
$67M 0.38%
155,929
-12,168
-7% -$5.44M
ABBV icon
66
AbbVie
ABBV
$458B
$66.5M 0.38%
445,943
+16,850
+4% +$2.47M
FTNT icon
67
Fortinet
FTNT
$113B
$66.4M 0.38%
1,132,262
+127,846
+13% +$8.46M
LOW icon
68
Lowe's Companies
LOW
$119B
$64.3M 0.37%
309,419
-20,931
-6% -$4.71M
PNC icon
69
PNC Financial Services
PNC
$99.7B
$63.9M 0.37%
520,191
-18,702
-3% -$2.35M
CDNS icon
70
Cadence Design Systems
CDNS
$94B
$63.3M 0.36%
270,361
-181,006
-40% -$42.4M
ELV icon
71
Elevance Health
ELV
$82B
$62.4M 0.36%
143,229
-2,040
-1% -$925K
LH icon
72
Labcorp
LH
$24.5B
$60.6M 0.35%
301,353
-47,570
-14% -$10M
P
73
Everpure Inc
P
$24.5B
$60.5M 0.35%
1,698,205
+575,866
+51% +$21.4M
WMT icon
74
Walmart Inc
WMT
$886B
$59.5M 0.34%
1,115,319
+44,094
+4% +$2.35M
VUG icon
75
Vanguard Growth ETF
VUG
$216B
$58M 0.33%
1,278,960
-29,184
-2% -$1.38M

Similar funds

Glenmede Trust's Q3 2023 Portfolio in Review

As of Q3 2023, Glenmede Trust held 1,393 positions worth $17.5B, down 0.71% from $17.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Glenmede Trust's Q3 2023 filing shows 110 new, 432 increased, 589 reduced and 137 closed positions. Its largest new stake was Kenvue: 1,442,581 shares worth $29M. The largest sale was Synopsys, an estimated $72.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Glenmede Trust's largest Q3 2023 buy was Kenvue: 1,442,581 shares worth $29M.
  • Glenmede Trust added most to TJX Companies in Q3 2023, an estimated $68.9M increase.
  • Glenmede Trust's biggest Q3 2023 reduction was Synopsys, cutting an estimated $72.2M.
  • Glenmede Trust fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $21.6M.
  • Glenmede Trust's ten largest holdings make up 22% of its $17.5B portfolio in Q3 2023.
  • Glenmede Trust opened 110 new positions and closed 137 in Q3 2023.
  • Glenmede Trust's portfolio value fell 0.71% quarter-over-quarter to $17.5B.

Based on Glenmede Trust's 13F filing for Q3 2023, filed 14 Nov 2023.